250 related articles for article (PubMed ID: 15698446)
1. Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration.
Lacour B; Lucas A; Auchère D; Ruellan N; de Serre Patey NM; Drüeke TB
Kidney Int; 2005 Mar; 67(3):1062-9. PubMed ID: 15698446
[TBL] [Abstract][Full Text] [Related]
2. Progressive accumulation of lanthanum in the liver of normal and uremic rats.
Slatopolsky E; Liapis H; Finch J
Kidney Int; 2005 Dec; 68(6):2809-13. PubMed ID: 16316357
[TBL] [Abstract][Full Text] [Related]
3. Tissue accumulation of lanthanum as compared to aluminum in rats with chronic renal failure--possible harmful effects after long-term exposure.
Nikolov IG; Joki N; Vicca S; Patey N; Auchère D; Benchitrit J; Flinois JP; Ziol M; Beaune P; Drüeke TB; Lacour B
Nephron Exp Nephrol; 2010; 115(4):e112-21. PubMed ID: 20424489
[TBL] [Abstract][Full Text] [Related]
4. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?
Behets GJ; Dams G; Vercauteren SR; Damment SJ; Bouillon R; De Broe ME; D'Haese PC
J Am Soc Nephrol; 2004 Aug; 15(8):2219-28. PubMed ID: 15284308
[TBL] [Abstract][Full Text] [Related]
5. Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats.
Neven E; Dams G; Postnov A; Chen B; De Clerck N; De Broe ME; D'Haese PC; Persy V
Nephrol Dial Transplant; 2009 Jun; 24(6):1790-9. PubMed ID: 19144999
[TBL] [Abstract][Full Text] [Related]
6. Development and reversibility of impaired mineralization associated with lanthanum carbonate treatment in chronic renal failure rats.
Bervoets AR; Oste L; Behets GJ; Dams G; Blust R; Marynissen R; Geryl H; De Broe ME; D'Haese PC
Bone; 2006 Jun; 38(6):803-10. PubMed ID: 16412714
[TBL] [Abstract][Full Text] [Related]
7. Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats.
Ben-Dov IZ; Pappo O; Sklair-Levy M; Galitzer H; Ilan Y; Naveh-Many T; Silver J
Nephrol Dial Transplant; 2007 Feb; 22(2):362-8. PubMed ID: 17090605
[TBL] [Abstract][Full Text] [Related]
8. Sulfate homeostasis, NaSi-1 cotransporter, and SAT-1 exchanger expression in chronic renal failure in rats.
Fernandes I; Laouari D; Tutt P; Hampson G; Friedlander G; Silve C
Kidney Int; 2001 Jan; 59(1):210-21. PubMed ID: 11135073
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
10. Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure.
Phan O; Maillard M; Malluche HH; Stehle JC; Funk F; Burnier M
Biomed Res Int; 2015; 2015():515606. PubMed ID: 26221597
[TBL] [Abstract][Full Text] [Related]
11. Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats.
Damment SJ; Shen V
Clin Nephrol; 2005 Feb; 63(2):127-37. PubMed ID: 15730055
[TBL] [Abstract][Full Text] [Related]
12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular transport and gastrointestinal absorption of lanthanum in chronic renal failure.
Bervoets AR; Behets GJ; Schryvers D; Roels F; Yang Z; Verberckmoes SC; Damment SJ; Dauwe S; Mubiana VK; Blust R; De Broe ME; D'Haese PC
Kidney Int; 2009 Feb; 75(4):389-98. PubMed ID: 19052535
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure.
Damment S; Secker R; Shen V; Lorenzo V; Rodriguez M
Nephrol Dial Transplant; 2011 Jun; 26(6):1803-12. PubMed ID: 21098011
[TBL] [Abstract][Full Text] [Related]
15. Intestinal absorption and biliary secretion of zinc in rats with chronic renal failure.
Chen SM; Liao JF; Kuo CD; Ho LT
Nephron Physiol; 2004; 96(4):p113-20. PubMed ID: 15122057
[TBL] [Abstract][Full Text] [Related]
16. Effects of efficient phosphate binding on bone in chronic renal failure rats.
Behets GJ; Gritters M; Dams G; De Broe ME; D'Haese PC
Ren Fail; 2005; 27(4):475-84. PubMed ID: 16060138
[TBL] [Abstract][Full Text] [Related]
17. Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.
Yamada S; Tatsumoto N; Tokumoto M; Noguchi H; Ooboshi H; Kitazono T; Tsuruya K
Calcif Tissue Int; 2015 Apr; 96(4):347-58. PubMed ID: 25511229
[TBL] [Abstract][Full Text] [Related]
18. Lanthanum carbonate as a first-line phosphate binder: the "cons".
Drüeke TB
Semin Dial; 2007; 20(4):329-32. PubMed ID: 17635823
[TBL] [Abstract][Full Text] [Related]
19. Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate.
Behets GJ; Verberckmoes SC; Oste L; Bervoets AR; Salomé M; Cox AG; Denton J; De Broe ME; D'Haese PC
Kidney Int; 2005 May; 67(5):1830-6. PubMed ID: 15840030
[TBL] [Abstract][Full Text] [Related]
20. Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.
Yamazaki-Nakazawa A; Mizobuchi M; Ogata H; Kumata C; Kondo F; Ono N; Koiwa F; Uda S; Kinugasa E; Akizawa T
Clin Exp Nephrol; 2014 Feb; 18(1):56-64. PubMed ID: 23740131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
